From: Effect of BRAFmutational status on expression profiles in conventional papillary thyroid carcinomas
Gene name | Gene symbol | BRAFwt PTC vs. BRAFmut PTC | BRAFwt PTC vs. TN | BRAFmut PTC vs. TN | |||
---|---|---|---|---|---|---|---|
 |  | FC1 | P | FC1 | P | FC1 | P 2 |
keratin 19 | KRT19 | -4.39 | 1.3E-09 | 2.37 | 2.0E-04 | 10.43 | 8.5E-13 |
potassium voltage-gated channel, shaker-related subfamily, beta member 1 | KCNAB1 | 7.66 | 6.4E-09 | 3.23 | 5.5E-04 | -2.37 | 5.7E-03 |
solute carrier family 26, member 4 | SLC26A4 | 7.59 | 4.3E-08 | 2.14 | 2.9E-02 | -3.55 | 4.0E-04 |
TBC1 domain family, member 2 | TBC1D2 | -2.39 | 4.4E-08 | 2.71 | 1.0E-07 | 6.48 | 3.3E-14 |
tumor protein D52-like 1 | TPD52L1 | -2.46 | 3.2E-07 | 2.22 | 3.6E-05 | 5.46 | 1.1E-11 |
TP53 apoptosis effector | PERP | -2.09 | 3.6E-07 | 2.97 | 6.9E-09 | 6.22 | 1.6E-14 |
Periplakin | PPL | -2.53 | 1.0E-06 | 2.92 | 1.9E-06 | 7.41 | 2.3E-12 |
growth differentiation factor 15 | GDF15 | -5.08 | 1.5E-06 | 2.41 | 1.1E-02 | 12.23 | 6.8E-09 |
deltex homolog 4 (Drosophila) | DTX4 | -3.31 | 3.5E-06 | 3.28 | 5.6E-05 | 10.86 | 8.4E-11 |
death-associated protein kinase 2 | DAPK2 | -2.45 | 1.0E-05 | 2.78 | 2.1E-05 | 6.83 | 7.6E-11 |
ethanolamine kinase 2 | ETNK2 | -2.51 | 1.9E-05 | 2.02 | 3.0E-03 | 5.07 | 1.3E-08 |
solute carrier family 34 (sodium phosphate), member 2 | SLC34A2 | -4.75 | 2.2E-05 | 8.86 | 2.2E-06 | 42.09 | 1.9E-11 |
transmembrane protein 98 | TMEM98 | -2.09 | 2.8E-05 | 2.24 | 9.8E-05 | 4.69 | 6.2E-10 |
gamma-glutamylcyclotransferase | GGCT | -2.52 | 3.1E-05 | 2.48 | 3.7E-04 | 6.26 | 2.3E-09 |
purine nucleoside phosphorylase | PNP | -3.55 | 3.4E-05 | 2.48 | 6.6E-03 | 8.82 | 4.7E-08 |
protein S (alpha) | PROS1 | -2.80 | 3.7E-05 | 5.78 | 1.4E-07 | 16.18 | 2.8E-12 |
FERM domain containing 4B | FRMD4B | 2.50 | 3.7E-05 | 5.04 | 7.3E-08 | 2.01 | 3.1E-03 |
mucin 1, cell surface associated | MUC1 | -2.29 | 5.6E-05 | 2.23 | 6.8E-04 | 5.12 | 6.6E-09 |
protein tyrosine phosphatase, receptor type, E | PTPRE | -2.22 | 6.0E-05 | 2.45 | 1.3E-04 | 5.43 | 1.5E-09 |
gamma-aminobutyric acid (GABA) A receptor, beta 2 | GABRB2 | -4.73 | 8.6E-05 | 2.82 | 1.7E-02 | 13.32 | 3.0E-07 |
metastasis associated in colon cancer 1 | MACC1 | -2.34 | 1.2E-04 | 2.15 | 2.3E-03 | 5.02 | 4.0E-08 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1 | CITED1 | -3.58 | 3.4E-04 | 2.56 | 1.8E-02 | 9.17 | 1.1E-06 |
laminin, beta 3 | LAMB3 | -3.13 | 3.4E-04 | 2.46 | 1.2E-02 | 7.70 | 6.7E-07 |
syndecan 4 | SDC4 | -2.22 | 4.3E-04 | 4.25 | 1.6E-06 | 9.45 | 1.2E-10 |
family with sequence similarity 129, member A | FAM129A | -2.21 | 4.3E-04 | 2.27 | 1.9E-03 | 5.03 | 9.8E-08 |
fibronectin 1 | FN1 | -2.60 | 4.9E-04 | 10.31 | 8.2E-09 | 26.78 | 1.5E-12 |
phosphodiesterase 5A, cGMP-specific | PDE5A | -2.82 | 7.1E-04 | 6.06 | 6.7E-06 | 17.11 | 6.5E-10 |
dual specificity phosphatase 5 | DUSP5 | -2.11 | 7.9E-04 | 2.16 | 3.1E-03 | 4.57 | 2.8E-07 |
chitinase 3-like 1 (cartilage glycoprotein-39) | CHI3L1 | -4.45 | 8.5E-04 | 3.50 | 1.4E-02 | 15.59 | 1.8E-06 |
cathepsin H | CTSH | -2.63 | 9.2E-04 | 5.31 | 1.1E-05 | 13.97 | 1.2E-09 |
trefoil factor 3 (intestinal) | TFF3 | 3.81 | 1.5E-05 | -2.86 | 2.6E-02 | -10.92 | 5.4E-06 |
met proto-oncogene (hepatocyte growth factor receptor) | MET | -2.27 | 2.7E-11 | 8.93 | 1.3E-08 | 20.25 | 4.6E-12 |